Popular Filters
Frequently Asked Questions
Introduction to sleep disorder
What are the top hospitals conducting sleep disorder research?
When it comes to clinical trials for sleep disorders, several top hospitals are making strides in the field. The University of Michigan in Ann Arbor is leading the way with an active trial focused on sleep disorders, along with three previously conducted studies. This renowned institution began its journey into understanding these conditions through clinical trials in 2019, and their ongoing efforts continue to shed light on this complex area of medicine. Meanwhile, at the Washington University School of Medicine in Saint Louis and the University of Virginia in Charlottesville, researchers are also dedicated to unraveling the mysteries behind sleep disorders. Both institutions have one active trial each as well as a couple of previous investigations under their belts. These recent initiatives highlight their commitment to advancing knowledge and improving treatment options for those struggling with sleep-related difficulties.
In addition to academic institutions, we find John D Dingell VAMC contributing significantly towards research on sleep disorders; located in Detroit they host an active clinical investigation pertaining solely to this subject matter. While they may not boast any completed trials yet, their unwavering dedication brings fresh hope to patients seeking effective interventions for better quality slumber nights.
These hospitals across different locations showcase how medical professionals from various corners of the country are coming together to explore novel ways of diagnosing and treating various sleep disorders such as insomnia or narcolepsy that affect millions worldwide every day. By conducting rigorous clinical trials and pushing boundaries within this realm of healthcare discovery, these institutions hold promise not only for patients who currently suffer but also those who will benefit from future breakthroughs aimed at improving overall well-being through better sleep hygiene practices
Which are the best cities for sleep disorder clinical trials?
Detroit, Michigan and Boston, Massachusetts emerge as the leading cities for sleep disorder clinical trials. Detroit hosts 2 active trials investigating Hyperoxia and other related areas. Meanwhile, Boston also offers 2 ongoing studies focused on Shoonya Meditators, Tasimelteon, and additional topics of interest. These cities provide promising opportunities for individuals seeking participation in cutting-edge research aimed at advancing our understanding and treatment of sleep disorders.
Which are the top treatments for sleep disorder being explored in clinical trials?
Clinical trials are actively exploring different treatments for sleep disorders, with one treatment in particular showing promise. Tasimelteon has emerged as a top contender, currently being tested in an active trial dedicated to sleep disorders. Introduced just last year in 2020, it is the focus of this innovative research aimed at improving the management and treatment of these conditions. As researchers delve deeper into understanding sleep disorders, tasimelteon may offer new hope for those struggling with disrupted sleep patterns.
What are the most recent clinical trials for sleep disorder?
New clinical trials offer hope for individuals struggling with sleep disorders, exploring potential treatments that could improve their quality of life. One such trial involves the use of tasimelteon in addressing sleep disorders. This Phase 3 study, which became available on 12/9/2020, aims to evaluate the efficacy and safety of this medication. Additionally, hyperoxia has shown promising results in earlier phases (Phase 1 and Phase 2) as a potential treatment for sleep disorder patients. These recent trials shed light on innovative approaches to address this prevalent issue and may pave the way for improved therapies in the future.
What sleep disorder clinical trials were recently completed?
Recently, several clinical trials investigating sleep disorders have reached completion, paving the way for potential advancements in treatment. These trials address a range of sleep-related conditions and provide valuable insights into improving patient outcomes. Notable among these studies is a trial focused on insomnia medication sponsored by Stanford University School of Medicine which concluded in February 2021. Additionally, a trial examining the effectiveness of cognitive-behavioral therapy for sleep apnea was completed at Harvard Medical School in July 2021. The culmination of these rigorous investigations signifies significant progress towards enhancing our understanding and management of various sleep disorders.